Literature DB >> 1903247

Detection of anti-Ro(SSA) antibodies by gel double diffusion and a 'sandwich' ELISA in systemic and subacute cutaneous lupus erythematosus and Sjögren's syndrome.

T T Provost1, L S Levin, R M Watson, M Mayo, H Ratrie.   

Abstract

A newly described Ro 'sandwich' ELISA was compared to the gel double diffusion technique to detect anti-Ro(SSA) antibodies in Sjögren's syndrome, systemic and subacute cutaneous lupus erythematosus patients. This study demonstrates that the ELISA assay increased the frequency of detection of anti-Ro(SSA) antibodies in these well defined connective tissue disease patients by approximately 5-10% compared to the gel double diffusion anti-Ro(SSA) antibody assay. The study also confirms that some patients make anti-Ro(SSA) antibodies directed solely at unique human Ro(SSA) antigen epitopes. We also detected the existence of a significant Sjögren's syndrome patient population failing to make significant anti-Ro(SSA) antibodies. We conclude from our study that the gel double-diffusion technique employing human spleen extract as a source of the Ro(SSA) antigen is, at present, the most cost-effective test to detect anti-Ro(SSA) antibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903247     DOI: 10.1016/0896-8411(91)90009-2

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  3 in total

1.  Practical evaluation of methods for detection and specificity of autoantibodies to extractable nuclear antigens.

Authors:  Susan M Orton; Amy Peace-Brewer; John L Schmitz; Kristie Freeman; William C Miller; James D Folds
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

2.  Antibodies to Sm and SS-A demonstrated by enzyme immunoassay. Correlation to clinical manifestations and disease activity in patients with systemic lupus erythematosus.

Authors:  M Gripenberg; A M Teppo; C Friman
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

3.  Anti-Ro antibody and cutaneous vasculitis in systemic lupus erythematosus.

Authors:  Márcio Veronesi Fukuda; Simone Chinwa Lo; Cláudia Salvini de Almeida; Samuel Katsuyuki Shinjo
Journal:  Clin Rheumatol       Date:  2008-11-25       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.